Systemic therapy of hepatocellular carcinoma: Are we making progress? Patricia RoxburghT. R. Jeffry Evans Review 29 October 2008 Pages: 1089 - 1104
Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome Aleksander KragTine BorupFlemming Bendtsen Review 18 November 2008 Pages: 1105 - 1140
Angiotensin receptor blockers in the treatment of NASH/NAFLD: Could they be a first-class option? Eugen Florin Georgescu Review 29 October 2008 Pages: 1141 - 1174
Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarin Jules I. SchwartzStephanie DunbarJohn A. Wagner Original Research 06 November 2008 Pages: 1175 - 1190
Corneal staining reductions observed after treatment with Systane® Lubricant Eye Drops Mike T. Christensen Original Research 29 October 2008 Pages: 1191 - 1199
Comparative effects of once-daily molsidomine in coronary patients from two distinct European ethnicities Roger MessinClaude DuboisJean-Pierre Famaey Original Research 10 November 2008 Pages: 1200 - 1214
Long-term safety and tolerability of epoetin zeta, administered intravenously, for maintenance treatment of renal anemia Conrad BaldamusStefan KrivoshievAngelika Bronn Original Research 16 October 2008 Pages: 1215 - 1228
Evaluating the long-term effect of ultrasound-guided needle puncture without aspiration on calcifying supraspinatus tendinitis Jiaan ZhuYeqing JiangBing Hu Original Research 08 November 2008 Pages: 1229 - 1234